Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABEO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Abeona Therapeutics Inc (ABEO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ABEO trades at $5.85, down 2.5% today, with neutral technical signals from moving averages and oscillators. The company shows mixed fundamentals with strong valuation metrics (P/E 7.86, EV/EBITDA 3.82) but negative profitability (net margin -246.42%, ROE -43.13%). Recent Q2 2026 earnings missed expectations despite revenue growth from ZEVASKYN therapy, while ongoing legal investigations create headwinds. Cash flow trends show improvement in 2025 but projected decline in 2026.
Investment outlook remains cautious despite analyst consensus favoring buys (66.7%). The stock offers attractive valuation multiples but faces significant operational challenges and profitability concerns. Key opportunities include ZEVASKYN commercialization progress and CMS reimbursement approval, while risks involve ongoing legal investigations, manufacturing issues, and sustained negative cash flow from operations.
Read full analysis

Key Stats

  • Market Cap
    $334.24M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $7.46
  • 52W Low
    $4.17
  • Typical Hold Time
    -
  • Enterprise Value
    $207.29M
  • Div Yield
    -
  • Trading Activity
    -
$5.86
52W Low: $4.17
11 Nov 2025
52W High: $7.46
12 Aug 2026

Track Abeona Therapeutics Inc (ABEO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.46, highlighting its annual price range. Buy and sell Abeona Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Most Recent News

Content is generated by Aura AI

US private employers added 12,000 jobs weekly on average in August, showing hiring acceleration.

For the four weeks ending August 22, 2026, US private employers added an average of 12,000 jobs per week, according to ADP's National Employment Report Pulse. This figure shows an acceleration in hiring compared to previous weeks, reflecting a positi...

Market News
4 hours ago
PRNewsWire
Neutral
US private employers added 12,000 jobs weekly on average in August, showing hiring acceleration.

Five top dividend stocks trade near 52-week lows, offering high yields for patient investors.

Five well-known dividend-paying companies—Clorox, Comcast, Duke Energy, General Mills, and VICI Properties—are currently trading near their 52-week lows, presenting attractive opportunities for income-focused investors. These stocks offer high divide...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Five top dividend stocks trade near 52-week lows, offering high yields for patient investors.

Inhibrx advances cancer drugs with FDA review for ozekibart due by April 2027

Inhibrx is progressing its cancer treatments ozekibart and INBRX-106, targeting rare cancers and large immuno-oncology markets. Ozekibart showed a 52% risk reduction in chondrosarcoma progression and strong responses in colorectal and Ewing sarcoma, ...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Inhibrx advances cancer drugs with FDA review for ozekibart due by April 2027
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $334.24M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $7.46
  • 52W Low
    $4.17
  • Typical Hold Time
    -
  • Enterprise Value
    $207.29M
  • Div Yield
    -
  • Trading Activity
    -
$5.86
52W Low: $4.17
11 Nov 2025
52W High: $7.46
12 Aug 2026

Track Abeona Therapeutics Inc (ABEO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.46, highlighting its annual price range. Buy and sell Abeona Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!